Heron Therapeutics (HRTX) EBITDA (2010 - 2026)
Heron Therapeutics (HRTX) reported EBITDA of -$8.1 million for Q1 2026, down 409.61% on a YoY basis from $2.6 million in Q1 2025, and down 175.29% quarter-over-quarter from -$2.9 million in Q4 2025.
Heron Therapeutics (HRTX) EBITDA (2010 - 2026) Analysis & Trends
Heron Therapeutics has reported EBITDA for 17 years, with the latest figure at -$8.1 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 409.61% year-over-year to -$8.1 million; the trailing twelve-month figure through Mar 2026 stood at -$30.9 million (down 297.89% YoY), and the FY2025 full-year result was -$20.2 million, down 48.78% from the prior year.
- EBITDA for Q1 2026 stood at -$8.1 million, down from -$2.9 million in the prior quarter.
- The five-year high for EBITDA was $3.6 million in Q4 2024, with the low at -$63.9 million in Q1 2022.
- Historically, EBITDA has averaged -$19.7 million across 5 years, with a median of -$10.7 million in 2023.
- Annual changes were most pronounced in 2025 — EBITDA surged 182.51% — and 2026, when it plunged 409.61%.
- Heron Therapeutics' EBITDA stood at -$19.8 million in 2022, then jumped by 45.99% to -$10.7 million in 2023, then jumped by 133.95% to $3.6 million in 2024, then plunged by 181.13% to -$2.9 million in 2025, then tumbled by 175.29% to -$8.1 million in 2026.
- The last three EBITDA figures came in at -$8.1 million (Q1 2026), -$2.9 million (Q4 2025), and -$17.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | -8.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.12 Mn |
| Dec 31, 2025 | -2.95 Mn |
| Sep 30, 2025 | -17.49 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | 2.62 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Sep 30, 2024 | -4.80 Mn |
| Jun 30, 2024 | -9.24 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -10.71 Mn |
| Sep 30, 2023 | -25.00 Mn |
| Jun 30, 2023 | -42.07 Mn |
| Mar 31, 2023 | -32.74 Mn |
| Dec 31, 2022 | -19.83 Mn |
| Sep 30, 2022 | -41.95 Mn |
| Jun 30, 2022 | -56.36 Mn |
| Mar 31, 2022 | -63.89 Mn |
| Dec 31, 2021 | -54.65 Mn |
| Sep 30, 2021 | -52.45 Mn |
| Jun 30, 2021 | -61.10 Mn |